Walgreens Boots Alliance, Inc. experienced its Day High at -5.02%, with its Day Low of 4.01%.
Advertisement
Analysts consider the price to earnings ratio to assess the firm’s valuation. The Stock now has a Weekly Volatility of 1.66% and Monthly Volatility of 1.49%. 666,616 shares of the company traded hands.
The consensus price target for Walgreens Boots Alliance (WBA) is $92.62 for the short term with a standard deviation of $6.53. Bank of America Corp. reaffirmed a buy rating and set a $78.66 price target (down from $94.00) on shares of Walgreens Boots Alliance in a report on Tuesday, June 7th. The corporation showed significant change in the EPS section with its current EPS of 2.9. Investors are waiting for 2016-10-20 when the company will report its quarterly statistics.
03/01/2016 – Walgreens Boots Alliance, Inc. was upgraded to “buy” by analysts at Mizuho.
The technical study highlights that Walgreens Boots Alliance, Inc. current is trading $0.00 points away or +0.00% from 50-day moving average of $81.49. The firm has a market capitalization of $87.62 billion, a PE ratio of 27.98 and a beta of 1.01. The company posted actual EPS for the last quarter of $1.18.
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company.
The firm also recently announced a quarterly dividend, which was paid on Monday, September 12th. Using this scale, a 1 would indicate a Strong Buy, and a 5 rating would represent a Strong Sell rating. To see the ratio analysis, the debt to equity ratio appeared as 0.14 for seeing its liquidity position. Following the sale, the director now directly owns 26,690 shares of the company’s stock, valued at approximately $2,171,231.50.
Several large investors have recently bought and sold shares of the stock. Williams Jones & Associates LLC raised its stake in Walgreens Boots Alliance by 1,302.9% in the second quarter. The stock established a negative trend of -3.58% in last week and indicated rise of 0.90% in previous month.
The current ratio for Walgreens Boots Alliance, Inc. CapWealth Advisors LLC increased its position in shares of Walgreens Boots Alliance by 30.0% in the first quarter. The Company is a pharmacy-led health and wellbeing company.
Advertisement
Walgreens Boots Alliance, Inc. It operates through three segments: Retail Pharmacy USA, which consists of the Walgreens business, including the operation of retail drugstores and convenient care clinics, in addition to providing specialty pharmacy services; Retail Pharmacy International, which consists of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations, and Pharmaceutical Wholesale, which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
